Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

CUSIP: 007002108

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
9,599,852
Total 13F shares
75,135,656
Share change
+41,749,451
Total reported value
$176,537,613
Put/Call ratio
185%
Price per share
$2.35
Number of holders
96
Value change
+$98,192,610
Number of buys
69
Number of sells
24

Security key

007002108

Report period

Q1 2024

Institutions

96

Top holders

10

Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ORBIMED ADVISORS LLC
13F
Company
87%
8,322,140
$15,728,845 31 Dec 2023
13F
RTW INVESTMENTS, LP
13F
Company
43%
4,134,631
$7,814,453 31 Dec 2023
13F
MORGAN STANLEY
13F
Company
29%
2,798,809
$5,289,749 31 Dec 2023
13F
COWEN AND COMPANY, LLC
13F
Company
28%
2,715,278
$5,131,875 31 Dec 2023
13F
BlackRock Finance, Inc.
13F
Company
23%
2,182,675
$4,125,256 31 Dec 2023
13F
Carlyle Group Inc.
13F
Company
22%
2,115,385
$3,976,924 31 Dec 2023
13F
VANGUARD GROUP INC
13F
Company
18%
1,685,075
$3,184,791 31 Dec 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
14%
1,321,587
$2,497,799 31 Dec 2023
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
9.1%
876,352
$1,656,305 31 Dec 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
8%
766,600
$1,449,000 31 Dec 2023
13F
JOHNSON & JOHNSON
13F
Company
7.2%
688,595
$1,301,445 31 Dec 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
6.9%
661,795
$1,250,938 31 Dec 2023
13F
STATE STREET CORP
13F
Company
6.7%
640,543
$1,210,626 31 Dec 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
5.8%
559,750
$1,056,000 31 Dec 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
5.4%
520,039
$982,874 31 Dec 2023
13F
NORGES BANK
13F
Company
4.5%
429,550
$811,850 31 Dec 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
3.8%
360,725
$681,770 31 Dec 2023
13F
D. E. Shaw & Co., Inc.
13F
Company
3.6%
346,619
$655,110 31 Dec 2023
13F
NORTHERN TRUST CORP
13F
Company
2.4%
232,085
$438,640 31 Dec 2023
13F
Schonfeld Strategic Advisors LLC
13F
Company
2.1%
200,100
$378,189 31 Dec 2023
13F
Nuveen Asset Management, LLC
13F
Company
2%
193,804
$366,289 31 Dec 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.6%
153,414
$289,636 31 Dec 2023
13F
FMR LLC
13F
Company
1.4%
135,914
$256,877 31 Dec 2023
13F
CITADEL ADVISORS LLC
13F
Company
1.4%
133,229
$251,803 31 Dec 2023
13F
Bank of New York Mellon Corp
13F
Company
1%
97,539
$184,349 31 Dec 2023
13F
EXCHANGE TRADED CONCEPTS, LLC
13F
Company
0.85%
81,986
$154,954 31 Dec 2023
13F
OCCUDO QUANTITATIVE STRATEGIES LP
13F
Company
0.79%
76,278
$144,165 31 Dec 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.72%
69,460
$131,279 31 Dec 2023
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.62%
59,650
$112,739 31 Dec 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.57%
54,800
$103,572 31 Dec 2023
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.54%
51,746
$97,800 31 Dec 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.5%
47,743
$90,235 31 Dec 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.49%
47,115
$89,040 31 Dec 2023
13F
DEUTSCHE BANK AG\
13F
Company
0.48%
45,706
$86,384 31 Dec 2023
13F
BARCLAYS PLC
13F
Company
0.44%
41,797
$78,996 31 Dec 2023
13F
CORNERCAP INVESTMENT COUNSEL INC
13F
Company
0.4%
38,209
$72,215 31 Dec 2023
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.38%
36,740
$69,439 31 Dec 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.36%
34,344
$64,910 31 Dec 2023
13F
SEI INVESTMENTS CO
13F
Company
0.32%
31,012
$58,613 31 Dec 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.3%
28,613
$54,078 31 Dec 2023
13F
Squarepoint Ops LLC
13F
Company
0.29%
28,240
$53,374 31 Dec 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.24%
23,012
$43,492 31 Dec 2023
13F
XTX Topco Ltd
13F
Company
0.24%
23,001
$43,472 31 Dec 2023
13F
UBS Group AG
13F
Company
0.24%
22,578
$42,672 31 Dec 2023
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.22%
20,674
$39,000 31 Dec 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.21%
19,830
$37,478 31 Dec 2023
13F
Cubist Systematic Strategies, LLC
13F
Company
0.2%
19,535
$36,921 31 Dec 2023
13F
Summit Trail Advisors, LLC
13F
Company
0.19%
18,000
$34,020 31 Dec 2023
13F
SIMPLEX TRADING, LLC
13F
Company
0.17%
16,540
$31,000 31 Dec 2023
13F
SG Americas Securities, LLC
13F
Company
0.17%
15,996
$30,000 31 Dec 2023
13F

Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q1 2024

As of 31 Mar 2024, Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,135,656 shares. The largest 10 holders included ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., TANG CAPITAL MANAGEMENT LLC, Balyasny Asset Management L.P., RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BlackRock Inc., and VANGUARD GROUP INC. This page lists 96 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
76
Q1 2024 holders
96
Holder diff
20
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .